[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334156-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334156-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","biglycan-promotes-tumour-proliferation-and-invasion-in-human-colon-cancers","Biglycan promotes tumour proliferation and invasion in human colon cancers","","Objective: Investigate the role of biglycan (BGN) in colon cancer progression. Methods: Correlate BGN mRNA levels with patient survival using Gene Expression Omnibus and The Cancer Genome Atlas, then apply Gene Set Enrichment Analysis to identify pathways linked to BGN. Perform in vitro experiments in HCT116 cells to assess proliferation, migration, invasion, cell-cycle control, and apoptosis, using Western blot and small interfering RNAs. Results: Higher BGN protein in tumors associates with shorter survival; BGN knockdown suppresses malignant behaviors, induces G0/G1 arrest, and promotes apoptosis, implicating MAPK signaling. Conclusion: BGN may drive progression via MAPK and represent a potential therapeutic target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/biglycan-promotes-tumour-proliferation-and-invasion-in-human-colon-cancers/334156/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/biglycan-promotes-tumour-proliferation-and-invasion-in-human-colon-cancers/334156.png","ImageObject",300,407,{"name":42,"@type":43},"Seraphina","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-26","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main objective of the study on biglycan in colon cancer?","Question",{"text":63,"@type":64},"The study investigates how biglycan (BGN) contributes to colon cancer progression.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were data sources used to connect BGN with patient outcomes?",{"text":68,"@type":64},"BGN mRNA levels were analyzed against patient survival using Gene Expression Omnibus datasets and The Cancer Genome Atlas, followed by Gene Set Enrichment Analysis to explore associated pathways.",{"name":70,"@type":61,"acceptedAnswer":71},"What effects does BGN knockdown have on colon cancer cells?",{"text":72,"@type":64},"In HCT116 cells, BGN knockdown inhibits proliferation, migration, and invasion, causes G0/G1 cell-cycle arrest, and promotes apoptosis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334156,1790785119,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":112,"preview_page_count":4},962075114101,"https://ap-avatar.wpscdn.com/avatar/e000253a75eb197efd?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780044092746381165","Biglycan promotes tumour proliferation and invasion in human colon cancers  \nBiyan Lu 1,2, Ying Zhu2, Guangliu Li2, Yongqiang Xu2, Chuangyu Wen3 and Weibiao Ye2   \nJournal of International Medical Research 2024, Vol. 52(11) 1–12! The Author(s) 2024 Article reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/03000605241300067](DOI: 10.1177/03000605241300067)[ ](DOI: 10.1177/03000605241300067)[journals.sagepub.com/home/imr](journals.sagepub.com/home/imr)  \nAbstract  \nObjective: To investigate the role of biglycan (BGN) in colon cancer progression.  \nMethods: The association between BGN mRNA levels and the survival time of patients with colon cancer was analysed by referencing data from the Gene Expression Omnibus and The Cancer Genome Atlas (TCGA). Gene Set Enrichment Analysis (GSEA) was conducted to explore gene sets and pathways associated with BGN. In vitro analyses were undertaken in HCT116 cells to analyse cell proliferation, migration, invasion, cell cycle control and apoptosis. GSEA, Western blot analysis and small interfering RNAs were used to explore the molecular mechanisms of BGNin colon cancer cells.  \nResults: Analysis of the pairs of tissues from colon cancer patients showed that BGN protein levels were higher in colon cancer tissues compared with adjacent non-tumour tissues. High BGN levels were significantly associated with shorter survival times. BGN knockdown inhibited cell proliferation, migration and invasion; and induced cell cycle arrest in the G0/G1 phase and promoted apoptosis in HCT116 cells. GSEA found that BGN might affect tumour progression via the mitogen-activated protein kinase (MAPK) signalling pathway.  \nConclusion: BGN might promote colon cancer progression via the MAPK signalling pathway and could be a potential target for future novel therapeutic strategies.  \nKeywords  \nColon cancer, biglycan, proliferation, invasion, mitogen-activated protein kinase  \nDate received: 3 July 2024; accepted: 25 October 2024  \n1 School of Health, Dongguan Polytechnic, Dongguan, Guangdong Province, China  \n2Department of Molecular Diagnostics, The Tenth Affiliated Hospital, Southern Medical University, Dongguan, Guangdong Province, China  \n3Department of Obstetrics and Gynaecology, The Tenth Affiliated Hospital, Southern Medical University, Dongguan, Guangdong Province, China Corresponding author:  \nWeibiao Ye, Department of Molecular Diagnostics, The Tenth Affiliated Hospital, Southern Medical University, 78 Wandao Road, Dongguan, Guandong 523018, China.  \nEmail: [billea@smu.edu.cn](billea@smu.edu.cn)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative  \nCommons Attribution-NonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages ([https://us.sagepub.com/en-us/nam/open-access-at-sage](https://us.sagepub.com/en-us/nam/open-access-at-sage)).  \nIntroduction  \nColon cancer is one of the most common malignant tumours of the digestive tract, which is characterized by extremely high morbidity and mortality rates, making it the fourth leading cause of cancer-related death worldwide.1 In recent years, the incidence of colon cancer in China has rapidly increased, severely threatening public health.2 Although the clinical outcomes for colon cancer patients have significantly improved with the development of new treatments, colon cancer remains a lethal disease, with a 5-year survival rate of only 42 .7% .1 Therefore, in-depth research into the pathogenesis of colon cancer is crucial for the development of effective treatment strategies and the improvement of patient survival.  \nBiglycan (BGN) is a member of the small leucine-rich ","cbCaimqB3D9iUhBZ","https://ap.wps.com/l/cbCaimqB3D9iUhBZ","pdf",1249682,12,"English","# Abstract\n## Objective, Methods, Results, Conclusion\n# Introduction\n## Colon cancer background and BGN biology\n# Patients and methods\n## Bioinformatics analysis","[{\"question\":\"What is the main objective of the study on biglycan in colon cancer?\",\"answer\":\"The study investigates how biglycan (BGN) contributes to colon cancer progression.\"},{\"question\":\"How were data sources used to connect BGN with patient outcomes?\",\"answer\":\"BGN mRNA levels were analyzed against patient survival using Gene Expression Omnibus datasets and The Cancer Genome Atlas, followed by Gene Set Enrichment Analysis to explore associated pathways.\"},{\"question\":\"What effects does BGN knockdown have on colon cancer cells?\",\"answer\":\"In HCT116 cells, BGN knockdown inhibits proliferation, migration, and invasion, causes G0/G1 cell-cycle arrest, and promotes apoptosis.\"}]","Biglycan promotes tumour proliferation and invasion in human colon cancers | PDF",1790005525]